PSIKOSIS PADA AUTOIMUN SEBUAH LAPORAN KASUS SISTEMIK LUPUS ERITEMATOSUS KOINSIDENSI DENGAN MULTIPLE SKLEROSIS

  • Deshinta Putri Mulya Departemen Ilmu Penyakit Dalam Universitas Gadjah Mada
  • Arief Darmawan RSUP DR. Sardjito, Yogyakarta, Indonesia

Abstract

Varied symptoms of Systemic lupus erythematosus make its diagnosis challenging. A 40 year old woman was admitted to the Emergency Room for self-talking, rambling and being rowdy. Psychiatric assessment showed an indication of organic hallucination. The patient had been undergoing neurologic treatment for four months due to multiple sclerosis with onset symptoms including of paraperese which was improved after taking steroids. In addition to neurologic symptoms, other conditions including mucous ulcers, malar rash, vasculitis, hair loss, and arthritis were found. The laboratory test indicated the presence of strong positive ANA profile in the RNP/Sm, Sm, SS-A native, Ro-52, SS-B and Ribosomal Protein. Patient’s condition significantly improved after undergoing treatment for Systemic lupus erythematosus flare with a coincidence of multiple sclerosis.

References

[1] Sanchez EC, Castillo MA, Gonzalez VP, Lopez FG dan Dıaz EP, “Coexistence of systemic lupus erythematosus and multiple sclerosis, A case report and literature review”, MSJournal-Experimental Translational and Clinical, April-June, 1–9, 2018.
[2] Dafna G, “Systemic Lupus Erythematosus And Sjögren's Syndrome”, Current Opinion in Rheumatology: September, p 430-437, 1996.
[3] Dendrou CA, Fugger L, Friese MA, “Immunopathology of multiple sclerosis”, Nat Rev Immunol, ;15(9):545-558, 2015.
[4] Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB, “Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord”, 12:638–46, 2010.
[5] Tay SH, Mak A, “Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?”, Rheumatology. 56:i14–24, 2016.
[6] Rose Jeppesen and Michael Eriksen Benros, “Autoimmune Diseases and Psychotic Disorders”, Frontiers in Psychiatry, March, Volume 10, 2019.
[7] Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F, “The antiphospholipid syndrome: from pathophysiology to treatment”,
Clin Exp Med, Aug;17(3):257-267, 2017.
[8] Wu Haifeng, Birmingham DJ, Rovin Brad, Hackshaw KV, Haddad, Haden, Yu CY dan Hebert LA, “D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus”, Clin J Am Soc Nephrol 3: 1628–1636, 2008.
[9] Rege S dan Mackworth-Young C, “Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome”, Translational Developmental Psychiatry, 3: 25, 2015.
[10] Abbas AK, Lichtman AH, Pillai S, Basic Imunology: Function and Disorders of the Immune System, (5th Edition), Philladelphia: Elsevier-Saunders Publishing; 2016.
Published
2022-10-20
Section
Articles
PDF
Abstract views: 512
downloads: 552